Healthcare & Life Sciences

MitrAssist

acquired
acquired
Stage
1
Investors

About

Developed a minimally invasive implant (the MitrAssist implant) that is placed on top of the heart's mitral valve to improve valve function and treat mitral regurgitation in patients who are not candidates for open-heart surgery.

Explore MitrAssist's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.